Search NLS News

We are happy to announce that we will be launching our updated and improved website this week, 16-22 September!

The 11th edition of NLSDays is being held in Malmö on September 18-19. Program Director, Marjo Puumalainen, gives us an inside look into the upcoming conference.

In the report Nordic added value in inter-ministerial Nordic co-operation, funded through NordForsk by the Nordic Council of Ministers, the researchers present six recommendations to optimize the use of the concept of ‘Nordic added value’ across Nordic institutions.

Evaxion Biotech has announced new clinical phase 2 data for its lead compound EVX-01.

The company receives the Designation from the U.S. FDA for emilimogene sigulactibac for the treatment of skin wounds in SAVI patients.

Both Danes and Swedes like to emphasize, and often make fun of, the more or less significant differences between our cultures.

Anna Wedell, Professor and Research Group Leader of the group Inborn Errors of Endocrinology and Metabolism at Karolinska Institutet and Director of the new Precision Medicine Center Karolinska, explains how research in rare diseases has evolved due to new technologies, and emphasizes that identifying synergies is essential for diagnosing and treating these conditions.

Cantargia has reported data from two clinical trials including nadunolimab combination therapy in 55 cancer patients.

The company has recently raised SEK 10 million in directed issue for a novel obesity-related study. The aim is to study drug tolerance and the effects of the company’s molecule on obesity. The Phase-2a-study will be conducted over the next year and the capital raised will support the study with the objective to assess the […]

IRLAB Therapeutics has announced that the company has been granted a new patent in Europe, which includes a new salt of mesdopetam used throughout the clinical development process and the process of its preparation. The patent that has now been granted extends the already strong patent protection for mesdopetam, the company’s most advanced project. “The […]